Chemoinformaics analysis of 2-HYDROXY-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-3-ONE
| Molecular Weight | 165.148 | nRot | 0 |
| Heavy Atom Molecular Weight | 158.092 | nRig | 12 |
| Exact Molecular Weight | 165.043 | nRing | 2 |
| Solubility: LogS | -2.225 | nHRing | 1 |
| Solubility: LogP | 0.714 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.5336 |
| nHD | 2 | BPOL | 10.1964 |
| QED | 0.582 |
| Synth | 2.893 |
| Natural Product Likeliness | 1.056 |
| NR-PPAR-gamma | 0.026 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.085 |
| HIA | 0.011 |
| CACO-2 | -5.02 |
| MDCK | 0.00000712 |
| BBB | 0.803 |
| PPB | 0.462588 |
| VDSS | 0.767 |
| FU | 0.47076 |
| CYP1A2-inh | 0.405 |
| CYP1A2-sub | 0.292 |
| CYP2c19-inh | 0.116 |
| CYP2c19-sub | 0.752 |
| CYP2c9-inh | 0.04 |
| CYP2c9-sub | 0.747 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.659 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.226 |
| CL | 2.373 |
| T12 | 0.828 |
| hERG | 0.009 |
| Ames | 0.372 |
| ROA | 0.315 |
| SkinSen | 0.757 |
| Carcinogencity | 0.307 |
| EI | 0.395 |
| Respiratory | 0.693 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.83711 |